Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kerathin is a biotechnology company that pioneered the use of keratin-based biomaterials for medical and regenerative applications. Founded to commercialize research from Wake Forest University, the company developed a platform for purifying human-derived keratin proteins into functional scaffolds, hydrogels, and coatings. These products are designed to promote wound closure, reduce pain, and manage inflammation in conditions such as chronic ulcers, severe burns, and radiation-induced skin damage. Kerathin's technology eventually formed the basis for KeraNetics, which continues to advance the clinical development of these keratin-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kerathin.